55 results
8-K
EX-99.1
kk4 g4swbnl
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
v44qrbpn lmr0h4uet
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-99.1
us3en
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K/A
EX-99.3
gbc509iglbyx
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.2
ezbhnuxli102tdv6
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.1
d82f1fatb 1v6tfg
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.1
w547en 44rw1fj
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
EX-10.2
7meecsg5guvxjcyt2a
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.5
60l8i6ew9x35cr
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
fz3b6qa krfzz3p
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
kvc7lembmvbxvvlyc y8
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
qk9ldymuu7d8jj2
28 Apr 23
Prospectus supplement
4:07pm